시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
암 치료제 시장 규모, 점유율, 성장 분석 : 치료 유형별, 약제 클래스별, 투여 경로별, 암 유형별, 최종사용자별, 유통 채널별, 지역별 - 산업 예측(2025-2032년)
Cancer Therapeutics Market Size, Share, and Growth Analysis, By Therapy Type, By Drug Class, By Route of Administration, By Cancer Type, By End User, By Distribution Channel, By Region - Industry Forecast 2025-2032
상품코드 : 1687502
리서치사 : SkyQuest
발행일 : 2025년 03월
페이지 정보 : 영문 157 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,671,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,973,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,276,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

암 치료제 시장 규모는 2023년에 2,106억 9,000만 달러로 평가되며, 2024년 2,315억 5,000만 달러에서 2032년에는 4,927억 5,000만 달러로 성장하며, 예측 기간(2025-2032년) CAGR은 9.9%로 성장할 전망입니다.

암 치료제 산업은 전 세계에서 암 발병률이 증가함에 따라 큰 성장을 이룰 것으로 예상됩니다. 종양학 연구에 대한 투자 증가와 첨단 치료 옵션에 대한 수요 증가는 이 분야의 기업에게 유망한 기회를 제공합니다. 또한 유전자 치료와 다양한 암종에 대한 맞춤 치료의 채택이 확대되고 있는 것도 이 시장을 촉진하고 있습니다. 또한 병용요법의 부상과 종양학 연구에 대한 정부 보조금 증가는 향후 수년간 매출을 증가시킬 것으로 예상됩니다. 그러나 약제 내성, 암의 불균일성, 치료로 인한 잠재적 부작용과 같은 문제는 진화하는 상황에서 여전히 의료 서비스 프로바이더에게 중요한 관심사입니다.

목차

서론

조사 방법

개요

시장 역학과 전망

주요 시장 인사이트

암 치료제 시장 규모 : 치료 유형별 & CAGR(2025-2032)

암 치료제 시장 규모 : 약제 클래스별 & CAGR(2025-2032)

암 치료제 시장 규모 : 투여 경로별 & CAGR(2025-2032)

암 치료제 시장 규모 : 암 유형별 & CAGR(2025-2032)

암 치료제 시장 규모 : 최종사용자별 & CAGR(2025-2032)

암 치료제 시장 규모 : 유통 채널별 & CAGR(2025-2032)

암 치료제 시장 규모 : 지역별 & CAGR(2025-2032)

경쟁 정보

주요 기업 개요

결론과 제안

KSA
영문 목차

영문목차

Cancer Therapeutics Market size was valued at USD 210.69 billion in 2023 and is poised to grow from USD 231.55 billion in 2024 to USD 492.75 billion by 2032, growing at a CAGR of 9.9% during the forecast period (2025-2032).

The cancer therapeutics industry is poised for significant growth as the global prevalence of cancer continues to rise. Increased investments in oncology research and an escalating demand for advanced treatment options are creating promising opportunities for companies in this sector. The market is further enhanced by the escalating adoption of gene therapies and personalized medicine tailored for various cancer types. Additionally, the rise of combination therapies and heightened government funding for oncology research are expected to drive sales in the coming years. However, challenges such as drug resistance, the heterogeneity of cancer, and potential adverse effects of treatments remain critical concerns for providers in this evolving landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cancer Therapeutics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cancer Therapeutics Market Segments Analysis

Global Cancer Therapeutics Market is segmented by Therapy Type, Drug Class, Route of Administration, Cancer Type, End User, Distribution Channel and region. Based on Therapy Type, the market is segmented into Chemotherapy, Immunotherapy, Targeted Therapy, Hormonal Therapy, Radiation Therapy, Stem Cell Transplant, Gene Therapy and Other Emerging Therapies. Based on Drug Class, the market is segmented into Alkylating Agents, Antimetabolites, Antitumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Hormone Therapies, Immune Checkpoint Inhibitors and Others. Based on Route of Administration, the market is segmented into Oral, Intravenous, Subcutaneous, Intramuscular, Topical and Others. Based on Cancer Type, the market is segmented into Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Skin Cancer, Blood Cancer (Leukemia, Lymphoma, etc.), Gastrointestinal Cancer, Gynecologic Cancer, Respiratory/Lung Cancer and Other Cancer Types. Based on End User, the market is segmented into Hospitals, Specialty Clinics and Cancer and Radiation Therapy Centers. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Cancer Therapeutics Market

The rise in cancer cases globally can be largely attributed to poor lifestyle choices and the increasing prevalence of unhealthy habits among individuals. This alarming trend has contributed to a substantial increase in the number of individuals diagnosed with cancer, thereby driving the demand for cancer therapeutics. As more people require effective treatments to combat this disease, the cancer therapeutics market is experiencing notable growth. The urgent need for innovative therapies to address the escalating cancer burden is highlighting the importance of investment and research in this market, further fueling its expansion in response to the growing health crisis.

Restraints in the Cancer Therapeutics Market

The rapid evolution of cancer cells and tumors has led to increasing resistance to various treatment modalities, significantly impacting the sales of cancer therapeutics. This resistance not only hampers the effectiveness of existing drugs but also poses a considerable challenge for the entire cancer therapeutics market, ultimately hindering its growth. As therapies become less effective against resistant tumors, the demand for innovative treatments rises, yet the slow pace of drug development and approval can exacerbate market stagnation. Consequently, the challenges posed by evolving cancer biology and drug resistance serve as a significant restraint on the progress of the cancer therapeutics market.

Market Trends of the Cancer Therapeutics Market

The Cancer Therapeutics market is witnessing a significant trend towards the integration of artificial intelligence (AI) in drug discovery and development processes. Companies are increasingly leveraging AI technologies to streamline research initiatives, identify novel drug targets, and enhance the efficacy of existing treatments. This trend not only accelerates innovation but also reduces time-to-market for new therapies. Additionally, AI is poised to play a broader role across various facets of the cancer therapeutics landscape, including personalized medicine and patient management, thereby driving efficiency and improving clinical outcomes. As this trend matures, it is expected to reshape the competitive dynamics of the market significantly.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Cancer Therapeutics Market Size by Therapy Type & CAGR (2025-2032)

Global Cancer Therapeutics Market Size by Drug Class & CAGR (2025-2032)

Global Cancer Therapeutics Market Size by Route of Administration & CAGR (2025-2032)

Global Cancer Therapeutics Market Size by Cancer Type & CAGR (2025-2032)

Global Cancer Therapeutics Market Size by End User & CAGR (2025-2032)

Global Cancer Therapeutics Market Size by Distribution Channel & CAGR (2025-2032)

Global Cancer Therapeutics Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기